David Dworaczyk, PhD, Shares New Data on Nasal Epinephrine for Anaphylaxis

Data presented at the American Society for Clinical Pharmacology and Therapeutics annual meeting show promise for Utuly, a novel intranasal epinephrine spray for treating anaphylaxis.

Related Keywords

United States ,American ,David Dworaczyk ,Grossig David Dworaczyk ,American Academy Of Allergy ,American Society For Clinical Pharmacology ,Drug Administration ,American Society ,Clinical Pharmacology ,Bryn Pharma ,American Academy ,Presents Phase ,Novel Intranasal ,